In 2004, CellResearch Corporation extracted Stem Cells from the Umbilical Cord Lining Membrane for the first time. Further research revealed that the Umbilical Cord Lining Membrane was also the richest source of Mesenchymal and Epithelial Stem Cells in the human body.

Yielding billions of stem cells there is economy in numbers, meaning that stem cell therapy is now finally within the reach of most if not all.

CellResearch Corporation is committed to availing the benefits of this breakthrough to everyone. Active stem cell research in numerous fields of medicine is currently under way for potential therapeutic opportunities. CellResearch Corporation is ready to extend its Umbilical Cord Lining Stem Cell Platform Technology to these stem cell research groups to accelerate translation.

The CREATE A BETTER WORLD: Stem Cell Research Initiative was launched in the early 2000s with the treatment of patients with chronic burns and wounds. Application of stem cells closed many of these wounds where conventional treatments had failed. To date, thousands of patients have benefited from these cord lining stem cell therapies in South East Asia. The CREATE A BETTER WORLD Initiative provided the therapies for these patients at highly subsidised rates or without charge.

CREATE A BETTER WORLD will continue to provide access to its Umbilical Cord Lining Stem Cell Platform technology, as well as provide treatments and support for clinics and doctors around the world caring for those who are most in need. To request for support from the Initiative, please contact CellResearch Corporation.

The work of CREATE A BETTER WORLD does not end with wound therapy. We hope to enable researchers to discover new therapies for a whole host of other diseases. To that end, CellResearch Corporation will, on request, provide free access to Umbilical Cord Lining Stem Cells to research institutions around the world, enabling them to further their work on refining stem cell therapies for a variety of diseases.

The work of institutions such as the Singapore National Eye Centre on corneal resurfacing can be found here, National Cancer Centre Singapore on diabetes can be found here, and the University Heart Centre in Hamburg on cell-based heart therapy can be found here.

All of these research initiatives were made possible through the contribution of cord lining stem cells from CellResearch Corporation. Other research partnerships using Cord Lining Stem Cells on Haemophilia A, neurological disorders, and Parkinson’s Disease can also be found on the website.

Recognising the immense potential of Umbilical Cord Lining Stem Cells for the treatment of chronic wounds, burns and ulcers, CREATE A BETTER WORLD is embarking on a mission to make stem cell treatment readily available to those in need around the world.

To that end, a part of the proceeds from the company’s businesses, which includes cord tissue banking licensing (in the form of GlobalCord) and skincare (CALECIM® Professional) will go towards the development of a therapeutic drug called CorliCyte™. CorliCyte™’s first indication is the healing of chronic diabetic wounds and CellResearch Corporation is confident that it will be able to make this product available to individuals suffering from chronic diabetic wounds, burns, ulcers and other complicated wounds around 2020. CorliCyte™ is currently progressing smoothly towards its first phase of USFDA trials.